Therefore, it is time to explore the pan-cancer evidence of the biological functions of TOP2A cross-carcinoma to reveal the pathogenesis of TOP2A in different cancers or the potential molecular mechanisms in the clinical prognosis, so as to develop more specific treatments for various cancer types. Here, TOP2A is linked to carcinoma.